Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Neoplasm Metastasis 1

Interventions

Fluorouracil 18 Oxaliplatin 17 Capecitabine 16 Leucovorin 13 Cisplatin 12 Gemcitabine 11 Drug Therapy 11 Irinotecan 10 Radiosurgery 9 Cetuximab 9 Bevacizumab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Cyclophosphamide 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × darolutamide × Clear all

NCT04641078 2024-02-28

DART

University Hospital, Ghent

Phase 2 Unknown

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡